Showing results (301-310 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
Search for immunobiological parameters predictive of clinical effects of OK-432 in patients with malignant ascitesM Kataoka, S Hashimoto, M Nanjo, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Effect of purified recombinant human erythropoietin on anemia in rats with experimental renal failure induced by five-sixth nephrectomyA Kawamura, M Higuchi, N Imai, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Humoral regulation of megakaryocytopoiesisA Grossi, A M Vannucchi, P Rossi FerriniBiotherapy (Dordrecht, Netherlands)|January 1, 1989
Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rateK Okamura, M Suzuki, T Chihara, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1988
Regulatory affairs and biotechnology in Europe. I. Introduction into good regulatory practiceB TryzelaarBiotherapy (Dordrecht, Netherlands)|January 1, 1996
Antitumor effects of human recombinant interleukin-1 alpha and etoposide against human tumor cells: mechanism for synergism in vitro and activity in vivoN Usui, K Matsushima, A M Pilaro, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Assessment of the effect of candidate anti-inflammatory treatments on the interaction between meningococci and inflammatory cells in vitro in a whole blood modelB Chan, P Kalabalikis, N Klein, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Augmentation of antitumor effect by combined administration with interleukin-2 and sizofiran, a single glucan, on murine EL-4 lymphomaY Kano, H Kakuta, J HashimotoBiotherapy (Dordrecht, Netherlands)|January 1, 1993
Phase IV group study of natural human interferon alpha (HLBI) on chronic myelogeneous leukaemiaS Arimori, H Terada, K Hayami, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Inhibition of in vitro HIV infection by dialysable leucocyte extractsC Fernandez-Ortega, M Dubed, O Ruibal, et al.Pageof 33